Marjorie E. Bowman
Ottawa, ON, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Autologous haematopoietic stem cell transplantation as a first-line disease-modifying therapy in patients with 'aggressive' multiple sclerosis.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: February 10, 2021
Neurotoxicity after hematopoietic stem cell transplant in multiple sclerosis.
Journal: Annals of clinical and translational neurology
Published: January 15, 2020
Research-to-Practice Gaps in Multiple Sclerosis Care for Patients with Subjective Cognitive, Mental Health, and Psychosocial Concerns in a Canadian Center.
Journal: International journal of MS care
Published: January 01, 2020
High serum neurofilament light chain normalizes after hematopoietic stem cell transplantation for MS.
Journal: Neurology(R) neuroimmunology & neuroinflammation
Published: January 11, 2019
Autologous hematopoietic stem cell transplantation improves fatigue in multiple sclerosis.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: September 26, 2018
Immunoablation and autologous haemopoietic stem-cell transplantation for aggressive multiple sclerosis: a multicentre single-group phase 2 trial.
Journal: Lancet (London, England)
Published: June 14, 2016
Cognitive fatigue in individuals with multiple sclerosis undergoing immunoablative therapy and hematopoietic stem cell transplantation.
Journal: Journal of the neurological sciences
Published: August 01, 2013
Cognitive change and neuroimaging following immunoablative therapy and hematopoietic stem cell transplantation in multiple sclerosis: A pilot study.
Journal: Multiple sclerosis and related disorders
Published: January 15, 2013
Showing 1-9 of 9
Last Updated: 09/26/2026